Subsets of Patients With Lupus Identified by Gene Expression Profiles Exhibit Differential Clinical Responsiveness to Baricitinib

Documenti analoghi

• Nociplasticity: A Proposed Concept to Understand the Symptomatology of Systemic Lupus Erythematosus
  di: David S. Pisetsky, et al.
  Pubblicazione: (2025)
• Different Immunologic Profiles Are Associated With Distinct Clinical Phenotypes in Longitudinally Observed Patients With Systemic Lupus Erythematosus
  di: Kieran Manion, et al.
  Pubblicazione: (2024)
• Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib
  di: Runa Kuley, et al.
  Pubblicazione: (2024)
• Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis
  di: Shervin Assassi, et al.
  Pubblicazione: (2025)
• Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification
  di: Mehmet Hocaoǧlu, et al.
  Pubblicazione: (2026)